Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma (TIL)

This study has been completed.
Information provided by (Responsible Party):
Nantes University Hospital Identifier:
First received: September 12, 2005
Last updated: October 3, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)